drugset / Trial / NCT00424294
A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the efficacy, safety and tolerability of CP-195543 and celecoxib dual therapy in subjects with rheumatoid arthritis
Timeline
- Start
- 2006-06
- Primary completion
- 2007-12
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CP-195543 | Small molecule | — | — |
| Comparator | Celecoxib | Other / unclassified | — | — |
| Background | Methotrexate | Small molecule | — | — |